PAS
LAB icon

Point72 Asia (Singapore)’s Standard BioTools LAB Stock Holding History

Point72 Asia (Singapore)’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-71,690
Closed -$86K – 1092
2025
Q2 		$86K Buy
+71,690
New +$79.5K 0.02% 502
2024
Q2 		– Sell
-303,213
Closed -$822K – 1279
2024
Q1 		$822K Buy
+303,213
New +$732K 0.21% 105

Other funds holding LAB

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
HBWM
Hollow Brook Wealth Management Katonah, New York $392M AUM 36.68% 1-Year Est. Return

Point72 Asia (Singapore)'s LAB Position: Q3 2025 in Review

Point72 Asia (Singapore) sold out of Standard BioTools (LAB) in Q3 2025, closing a stake of 71,690 shares — an estimated $86K sold.

Point72 Asia (Singapore) first reported a position in LAB in Q1 2024 and held it in 2 quarters. The position peaked at $822K in Q1 2024. 155 funds tracked by Wall St. Rank hold LAB as of Q3 2025.

  • Point72 Asia (Singapore) reported no remaining Standard BioTools position as of Q3 2025 after selling out during the quarter.
  • Point72 Asia (Singapore) sold 71,690 Standard BioTools shares in Q3 2025, an estimated $86K.
  • Point72 Asia (Singapore) first reported a position in Standard BioTools in Q1 2024 and held it in 2 quarters.
  • Point72 Asia (Singapore)'s Standard BioTools position peaked at $822K in Q1 2024.
  • 155 funds tracked by Wall St. Rank held Standard BioTools as of Q3 2025.

Based on Point72 Asia (Singapore)'s 13F filing for Q3 2025, filed 14 Nov 2025.